It was worth noting that these results were strongly in accordance with the proliferation phenotype in phycocyanin-treated cells, which indicated that phycocyanin exerted an anti-proliferative function through down-regulation of RIPK1 in NSCLC cells. The gene discussed is RIPK1; the disease is non-small cell lung carcinoma.